The BRET signal resulting from ligand stimulation was calculated by subtracting the BRET ratio for the vehicle-treated cells from the ligand-stimulated cells of the same aliquot
#HealthNews #PharmaNews #GSK #LiverDisease #Biotech #MedicalInnovation #NextClickNews To view or add a comment, sign in -1 : GLP-1 receptor agonists are redefining how we manage type 2 diabetes and obesity and these companies are leading the way: Novo Nordisk Ozempic, Wegovy, Rybelsus Eli Lilly Mounjaro, Trulicity AstraZeneca, Sanofi Also making significant contributions with drugs like Bydureon, Adlyxin, and Soliqua With GLP-1 therapies gaining global traction due to their metabolic and cardiovascular benefits, the competition is fierce and innovation is rapid
If people with T2D are suffering from vomiting, drowsy, unable to keep fluids down and/or have persistent diarrhoea, medical help should be sought immediately
Our experienced, licensed clinicians